EWM
ABBV icon

EPG Wealth Management’s AbbVie ABBV Stock Holding History

EPG Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$536K Sell
2,466
-100
-4% -$22.2K 0.15% 141
2025
Q4 		$586K Buy
2,566
+182
+8% +$41.5K 0.16% 135
2025
Q3 		$552K Sell
2,384
-2
-0.1% -$407 0.15% 138
2025
Q2 		$443K Sell
2,386
-2,439
-51% -$453K 0.13% 147
2025
Q1 		$1.01M Buy
4,825
+23
+0.5% +$4.47K 0.28% 104
2024
Q4 		$853K Sell
4,802
-1,193
-20% -$219K 0.22% 120
2024
Q3 		$1.18M Buy
+5,995
New +$1.12M 0.3% 94
2024
Q2 		– Sell
-7,225
Closed -$1.2M – 86
2024
Q1 		$1.32M Sell
7,225
-32
-0.4% -$5.51K 0.32% 85
2023
Q4 		$1.26M Sell
7,257
-73
-1% -$10.6K 0.33% 84
2023
Q3 		$1.09M Buy
7,330
+197
+3% +$28.9K 0.33% 80
2023
Q2 		$961K Sell
7,133
-139
-2% -$20.4K 0.28% 90
2023
Q1 		$1.16M Sell
7,272
-2,172
-23% -$332K 0.37% 74
2022
Q4 		$1.53M Buy
9,444
+177
+2% +$27.1K 0.58% 34
2022
Q3 		$1.24M Buy
9,267
+572
+7% +$82.1K 0.51% 42
2022
Q2 		$1.33M Buy
8,695
+107
+1% +$16.4K 0.57% 42
2022
Q1 		$1.39M Buy
8,588
+597
+7% +$86.7K 0.48% 49
2021
Q4 		$1.08M Buy
7,991
+573
+8% +$67.7K 0.38% 56
2021
Q3 		$800K Buy
7,418
+1,010
+16% +$115K 0.32% 68
2021
Q2 		$722K Buy
6,408
+2,308
+56% +$260K 0.31% 80
2021
Q1 		$444K Buy
4,100
+36
+0.9% +$3.85K 0.22% 105
2020
Q4 		$435K Buy
4,064
+29
+0.7% +$2.79K 0.26% 89
2020
Q3 		$353K Buy
4,035
+116
+3% +$10.9K 0.26% 89
2020
Q2 		$385K Buy
3,919
+605
+18% +$53.3K 0.27% 88
2020
Q1 		$253K Buy
3,314
+2,902
+704% +$247K 0.19% 99
2019
Q4 		$37K Buy
+412
New +$34.2K 0.03% 267

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EPG Wealth Management's ABBV Position: Q1 2026 in Review

EPG Wealth Management reduced its AbbVie (ABBV) stake by 3.9% in Q1 2026, selling an estimated $22.2K and leaving 2,466 shares worth $536K. The position accounts for 0.15% of the portfolio, ranked #141.

EPG Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.53M in Q4 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • EPG Wealth Management held 2,466 shares of AbbVie worth $536K as of Q1 2026.
  • EPG Wealth Management sold 100 AbbVie shares in Q1 2026, an estimated $22.2K.
  • AbbVie made up 0.15% of EPG Wealth Management's portfolio in Q1 2026, its #141 holding.
  • EPG Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
  • EPG Wealth Management's AbbVie position peaked at $1.53M in Q4 2022.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on EPG Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.